| P2093 | author name string | Fang Zhang | |
| | Chun-Mei Liu | |
| | Chun-Lei Xu | |
| P2860 | cites work | Brain tumor stem cells: Molecular characteristics and their impact on therapy | Q27003138 |
| | Training stem cells for treatment of malignant brain tumors | Q27006790 |
| | Nanoscale drug delivery systems and the blood-brain barrier | Q27026978 |
| | Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study | Q27334453 |
| | Gliomas and the vascular fragility of the blood brain barrier | Q28081953 |
| | Blood-brain barrier disruption by continuous-wave radio frequency radiation | Q48439831 |
| | Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide | Q48476305 |
| | Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging-guided focused ultrasound | Q48558167 |
| | Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution | Q48820159 |
| | In vivo MR quantification of superparamagnetic iron oxide nanoparticle leakage during low-frequency-ultrasound-induced blood-brain barrier opening in swine | Q48867104 |
| | Influence of short-chain cell-penetrating peptides on transport of doxorubicin encapsulating receptor-targeted liposomes across brain endothelial barrier | Q48867737 |
| | Improving efficiency of adriamycin crossing blood brain barrier by combination of thermosensitive liposomes and hyperthermia | Q49105829 |
| | Pulsed high-intensity focused ultrasound enhances the relative permeability of the blood-tumor barrier in a glioma-bearing rat model | Q50246200 |
| | The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide. | Q53634862 |
| | Glioblastoma multiforme: can neural stem cells deliver the therapeutic payload and fulfill the clinical promise? | Q54496034 |
| | Dual-targeting upconversion nanoprobes across the blood-brain barrier for magnetic resonance/fluorescence imaging of intracranial glioblastoma. | Q55461293 |
| | Facilitated brain delivery of poly (ethylene glycol)–poly (lactic acid) nanoparticles by microbubble-enhanced unfocused ultrasound | Q59159008 |
| | A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus | Q63343005 |
| | Drug delivery across the blood-brain barrier | Q86710293 |
| | Peptide-based glioma-targeted drug delivery vector gHoPe2. | Q39204672 |
| | CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells | Q39206523 |
| | Hyperthermia promotes apoptosis and suppresses invasion in C6 rat glioma cells. | Q39275152 |
| | Recent developments in nanoparticle-based siRNA delivery for cancer therapy | Q39386763 |
| | The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. | Q39405630 |
| | The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model. | Q39408907 |
| | Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. | Q39670726 |
| | Magnetic targeting of nanoparticles across the intact blood-brain barrier | Q40954233 |
| | Blood-brain barrier alteration after microwave-induced hyperthermia is purely a thermal effect: I. Temperature and power measurements | Q41869003 |
| | Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme | Q42060733 |
| | Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma | Q42094345 |
| | Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity | Q42248592 |
| | Glioma and glioblastoma - how much do we (not) know? | Q42578340 |
| | Treatment of malignant glioma using hyperthermia | Q42844696 |
| | Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment | Q43088262 |
| | Application of nanoparticles on diagnosis and therapy in gliomas. | Q43165459 |
| | Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes | Q43830296 |
| | Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistribution and transfection | Q44118023 |
| | Transport of nanoparticles through the blood-brain barrier for imaging and therapeutic applications | Q44696669 |
| | Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy | Q45190842 |
| | Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide | Q45360534 |
| | Blood-brain barrier molecular trojan horse enables imaging of brain uptake of radioiodinated recombinant protein in the rhesus monkey. | Q46039689 |
| | Chitosan nanoparticles are efficient carriers for delivering biodegradable drugs to neuronal cells | Q46955479 |
| | Effects of transcranial ultrasound and intravenous microbubbles on blood brain barrier permeability in a large animal model | Q47406084 |
| | Phase I study of GRN1005 in recurrent malignant glioma | Q48194717 |
| | Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group | Q48271471 |
| | Randomized study of paclitaxel and tamoxifen deposition into human brain tumors: implications for the treatment of metastatic brain tumors | Q48404556 |
| | Tight junctions of the blood-brain barrier | Q28145432 |
| | Drug targeting to the brain | Q28305371 |
| | In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma | Q28487205 |
| | Cellular host responses to gliomas | Q28730429 |
| | Focused ultrasound delivery of Raman nanoparticles across the blood-brain barrier: potential for targeting experimental brain tumors | Q30407973 |
| | Drug delivery systems, CNS protection, and the blood brain barrier | Q30432845 |
| | Site-specific opening of the blood-brain barrier | Q30434041 |
| | Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model | Q30435074 |
| | Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression | Q30438915 |
| | Focused ultrasound delivers targeted immune cells to metastatic brain tumors | Q30441716 |
| | Combining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview | Q30442623 |
| | Evaluation of the increase in permeability of the blood-brain barrier during tumor progression after pulsed focused ultrasound | Q30470304 |
| | Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment | Q30474002 |
| | Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma | Q30577878 |
| | A cell-penetrating peptide based on the interaction between c-Src and connexin43 reverses glioma stem cell phenotype. | Q30579545 |
| | Advances and challenges in the treatment of glioblastoma: a clinician's perspective | Q30620774 |
| | Current approaches to the treatment of metastatic brain tumours | Q33696559 |
| | Charting the course across the blood-brain barrier | Q33779922 |
| | Magnetic nanoformulation of azidothymidine 5'-triphosphate for targeted delivery across the blood-brain barrier | Q33831400 |
| | Minimally invasive molecular delivery into the brain using optical modulation of vascular permeability | Q33901944 |
| | From the bench to the bedside: Sleeping when you're awake, lasers and the blood-brain barrier, neurons with a taste for lactate, and more…. | Q33980196 |
| | Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound | Q34003611 |
| | Migration capacity of human umbilical cord mesenchymal stem cells towards glioma in vivo | Q34095283 |
| | Experimental approaches for the treatment of malignant gliomas | Q34127138 |
| | Cerebrovascular and metabolic effects on the rat brain of focal Nd:YAG laser irradiation | Q34152007 |
| | Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms | Q34154786 |
| | The use of neural stem cells in cancer gene therapy: predicting the path to the clinic | Q34217778 |
| | Stem cells as therapeutic vehicles for the treatment of high-grade gliomas | Q34240433 |
| | Induction of cell death in a glioblastoma line by hyperthermic therapy based on gold nanorods. | Q34278713 |
| | Drug delivery strategies for the treatment of malignant gliomas | Q34313142 |
| | Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events | Q34344850 |
| | Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? | Q34367038 |
| | Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM? | Q34383339 |
| | Cell-penetrating Peptide-mediated therapeutic molecule delivery into the central nervous system | Q38133554 |
| | Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages | Q38180964 |
| | Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors. | Q38184764 |
| | Brain stem cells as the cell of origin in glioma. | Q38190954 |
| | Transferrin receptor-mediated endocytosis: a useful target for cancer therapy | Q38191445 |
| | Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review | Q38200847 |
| | Molecular neuro-oncology and the challenge of the blood-brain barrier | Q38244806 |
| | Transmembrane proteins of the tight junctions at the blood-brain barrier: structural and functional aspects | Q38272608 |
| | Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier | Q38351134 |
| | A myristoylated cell-penetrating peptide bearing a transferrin receptor-targeting sequence for neuro-targeted siRNA delivery | Q38862070 |
| | Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems. | Q38974236 |
| | Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas. | Q39008799 |
| | Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting | Q39013477 |
| | Transport rankings of non-steroidal antiinflammatory drugs across blood-brain barrier in vitro models | Q39030221 |
| | Choline transporter-targeting and co-delivery system for glioma therapy | Q39102426 |
| | Solid lipid nanoparticles carrying chemotherapeutic drug across the blood-brain barrier through insulin receptor-mediated pathway | Q39132452 |
| | Transcriptional differences between normal and glioma-derived glial progenitor cells identify a core set of dysregulated genes. | Q39145031 |
| | The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells | Q39198011 |
| | Characterization of a novel cell penetrating peptide derived from human Oct4. | Q34504889 |
| | The blood-brain barrier and cancer: transporters, treatment, and Trojan horses | Q34577796 |
| | Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization | Q34701455 |
| | Cell-mediated drug delivery. | Q34709440 |
| | Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier. | Q34985892 |
| | Novel central nervous system drug delivery systems | Q35064473 |
| | Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro | Q35067385 |
| | Fighting fire with fire: the revival of thermotherapy for gliomas | Q35089633 |
| | Experimental use of photodynamic therapy in high grade gliomas: a review focused on 5-aminolevulinic acid | Q35183010 |
| | A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma | Q35256949 |
| | Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography. | Q35377505 |
| | New therapeutic approaches for malignant glioma: in search of the Rosetta stone | Q36224493 |
| | Brain protection from stroke with intravenous TNFα decoy receptor-Trojan horse fusion protein | Q36296365 |
| | Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse. | Q36420900 |
| | Function of the blood-brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of glioma | Q36497633 |
| | Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents. | Q36612939 |
| | Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal | Q37016591 |
| | Cell-penetrating peptides: from molecular mechanisms to therapeutics. | Q37110276 |
| | Assessment of three techniques for delivering stem cells to the heart using PET and MR imaging. | Q37283846 |
| | Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies | Q37396577 |
| | Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors. | Q37464021 |
| | Impact of perfusion map analysis on early survival prediction accuracy in glioma patients | Q37474416 |
| | Antitumor effects of high-temperature hyperthermia on a glioma rat model | Q37652558 |
| | Could nanoparticle systems have a role in the treatment of cerebral gliomas? | Q37855057 |
| | Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier | Q37855817 |
| | Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment | Q37889662 |
| | Nanoparticle-labeled stem cells: a novel therapeutic vehicle | Q37980117 |
| | The disturbed blood-brain barrier in human glioblastoma | Q37990264 |
| | Challenges in drug delivery to the brain: nature is against us. | Q38011540 |
| | The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery | Q38046928 |
| | Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications | Q38050182 |
| | Advances in stem cell therapy against gliomas | Q38093919 |
| | Pseudoprogression after glioma therapy: a comprehensive review | Q38094809 |
| | Blood-brain barrier structure and function and the challenges for CNS drug delivery | Q38100970 |
| | Receptor-mediated endocytosis and brain delivery of therapeutic biologics | Q38120524 |
| | Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerations | Q38128898 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | blood–brain barrier | Q221694 |
| | brain tumor | Q233309 |
| | glioma | Q1365309 |
| | antineoplastic | Q2853144 |
| | drug delivery system | Q64829245 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 2089-2100 | |
| P577 | publication date | 2015-04-09 | |
| P1433 | published in | Drug Design, Development and Therapy | Q2566724 |
| P1476 | title | Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma | |
| P478 | volume | 9 | |